Teradyne Q2 Earnings Beat Already Priced In; No Change to Cautious Stance

What happened

Teradyne reported second-quarter 2026 revenue of $1.329 billion and GAAP EPS of $2.38, driven by record AI-related semiconductor test demand. A post-earnings Zacks article highlights the importance of comparing key metrics to Wall Street estimates and prior-year figures, but adds no new data beyond the already-reported results. Our DeepValue master report already incorporates these numbers and maintains a WAIT rating, citing a rich valuation at 51.7 times trailing earnings and persistent shipment volatility reflected in below-Q2 guidance for the third quarter. While the quarter beat consensus on both top and bottom lines, the stock reaction suggests the market had anticipated the strength, leaving no margin of safety at current levels. The investment thesis remains unchanged: Teradyne is a high-quality AI-test beneficiary, but evidence of sustained, smooth demand beyond 2026 is needed before committing fresh capital.

Implication

The earnings release confirms robust AI-driven demand but also reinforces the lumpy pattern, with management guiding Q3 revenue below Q2. At these multiples, investors are betting on a flawless 2027 cycle extension. The prudent course is to wait for Q3 results to either validate that AI test intensity is smoothing out the typical semiconductor cycle or to signal a peak. Until then, the risk/reward is unfavorable.

Thesis delta

No change. The Q2 results align with our base-case expectations and were already embedded in our WAIT rating. The article adds no new competitive, operational, or macro insight that would alter our probability-weighted scenarios or valuation trigger levels.